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Collectins are collagenous lectins present in blood, respiratory lining
fluid, and other mucosal secretions that play important roles in innate
defense against infection. The collectin, surfactant protein D (SP-D),
limits infection by viruses and bacteria in the respiratory tract, eye,
and female genital tract. Multimeric SP-D has strong antiviral activity
and is a potent viral and bacterial agglutinin and opsonin; however,
trimers composed of the neck and carbohydrate recognition domain
(hSP-D-NCRD) of SP-D lack these activities. We now show that, in
contrast, a trimeric neck and CRD construct of bovine serum collectin
CL-46 induces aggregation of influenza A virus (IAV) and potently
increases IAV uptake by neutrophils. CL-46-NCRD showed calcium-
dependent and sugar-sensitive binding to both neutrophils and IAV.
Replacement of specific residues of the CRD of human SP-D with
those found in bovine serum collectins conferred opsonizing activity.
The most effective substitution involved replacement of arginine 343
with valine (hSP-D-NCRD/R343V). hSP-D-NCRD/R343V greatly
increased viral uptake by neutrophils and monocytes and also poten-
tiated neutrophil respiratory burst responses. These effects were fur-
ther increased by cross-linking of hSP-D-NCRD/R343V trimers with
MAbs directed against areas of the hSP-D-NCRD not involved in
viral binding. Unlike the wild-type human SP-D hSP-D-NCRD,
hSP-D-NCRD/R343V also induced viral aggregation. These results
indicate that collectins can act as opsonins for IAV even in the
absence of the collagen domain or higher order multimerization. This
may involve increased affinity of individual CRDs for glycoconju-
gates displayed on host cells or the viral envelope.
influenza virus; neutrophils; CL-46
INFLUENZA VIRUSES REMAIN a major cause of morbidity and
mortality and have the potential to cause massive mortality if
novel pandemic strains emerge through reassortment of human
and avian strains or direct adaptation of avian strains to humans
(as appears to have occurred in 1918; Refs. 29, 33). Certain
groups of subjects are known to be more susceptible to adverse
effects of influenza infection, including the very young and old
and subjects with a variety of comorbid conditions. It is likely
that innate host defense mechanisms play an important role in
defense against novel strains associated with antigenic drift or
shift. These defense mechanisms may play a greater role in
more vulnerable subjects (e.g., those who are immunocompro-
mised in other ways).
We (4, 5, 18, 26) and others (24) have extensively studied
the role of collectins in the early defense against influenza A
virus (IAV). Mice lacking either surfactant protein A (SP-A) or
SP-D experience greater viral replication, inflammation, and
illness in the first several days after infection with IAV strains
known to be susceptible to inhibition by these host defense
lectins in vitro (7, 26, 38). Host defense against IAV can be
restored in these mice by instillation or overexpression of
wild-type forms of rat SP-D. A trimeric recombinant form of
rat SP-D (rSP-Dser15,20, which lacks the ability to form
multimers due to replacement of cysteines in the NH2 termi-
nus) can restore antiviral activity in SP-D / mice when
highly overexpressed, even though this form of SP-D does not
improve other aspects of the abnormal phenotype of these mice
(38). In vitro, natural human SP-D trimers have substantially
reduced activity against IAV (23). These and other results
imply that multimerization of SP-D is important for some of its
functional activities (10, 11, 13).
The SP-D gene was duplicated in bovidae resulting in at
least three additional related collectins, all of which are present
in serum, conglutinin, CL-43, and CL-46 (8). These bovine
serum collectins are structurally similar to SP-D; however,
CL-43 is distinctive in that it only occurs as trimers in vivo and
in vitro, whereas the others form dodecameric structures sim-
ilar to SP-D (9, 12, 28). The bovine collectins also have
distinctive monosaccharide binding preferences compared with
SP-D. Whereas SP-D has highest affinity for glucose and
inositol, bovine conglutinin and CL-46 have higher affinity for
N-acetylglucosamine (GlcNAc) and mannose, and CL-43 has
higher affinity for mannose, than for glucose. We have dem-
onstrated that conglutinin and CL-43 have strong IAV neutral-
izing activity and that the intrinsic viral neutralizing activity of
the carbohydrate recognition domain (CRD) of conglutinin
exceeds that of SP-D (12, 14, 21). The latter conclusion was
based on production of a chimeric full-length collectin con-
taining the NH2 terminus and collagen domain of SP-D, cou-
pled to the neck and carbohydrate recognition domain (NCRD)
of conglutinin, which was shown to have increased IAV
inhibiting activity compared with wild-type SP-D. Further-
more, we have developed NCRD constructs of CL-43 and
SP-D (lacking NH2-terminal and collagen domains) and found
that the NCRD of CL-43 had viral neutralizing activity,
whereas those of human or rat SP-D did not (4). Crystallo-
graphic studies of SP-D have shown the calcium ion at the
sugar-binding site is flanked by hydrophilic amino acid resi-
dues with long side chains, Arg343 or Lys343 and Asp325 or
Asn325, depending on the species. Table 1 compares the
primary structure of this region of the NCRD of SP-D, CL-46,
and other serum collectins. Mutagenesis experiments have
shown that ligand binding preferences can be altered via
substitutions at one or both of these sites (4, 5). Introduction of
a three amino acid (arginine, alanine, and lysine; RAK) insert
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into the hSP-D-NCRD of SP-D at the same location that this
insert is found in CL-43 conferred neutralizing activity. Similar
results were obtained with an AAA insert in the same location.
The serum collectins mannose-binding lectin (MBL), CL-43,
CL-46, and conglutinin all have a hydrophobic amino acid
(valine or isoleucine) at position 343 in their NCRD, whereas
SP-D and SP-A have an arginine in this location. Recently, we
found that introducing such substitutions (hSP-D-NCRD/
R343V or hSP-D-NCRD/R343I) in hSP-D-NCRD results in
marked increase in viral neutralizing activity. This increase is
much more pronounced than that afforded by the RAK or AAA
insertions.
Prior studies have shown that collectins are potent opsonins
for viruses and bacteria, strongly increasing uptake of various
pathogens by phagocytes (11, 18, 21, 22). In addition, collec-
tins can potentiate activation of phagocytes when bounded to
microbial ligands (36). Several lines of evidence support the
hypothesis that receptors for collectin NH2 termini and colla-
gen domains may be critical in mediating these effects (2, 6,
37). With respect to IAV, we have shown that dodecamers or
multimers of SP-D, MBL, SP-A, or conglutinin potentiate viral
uptake and virus-induced respiratory burst responses by neu-
trophils (1, 13, 15). In the case of SP-D, multimerization of the
collectin is important for these effects since full-length trimers
or trimers of just the NCRD of SP-D lack opsonizing activity.
In contrast, we found that CL-43 trimers and the NCRD of
CL-43, or hSP-D-NCRD containing the RAK sequence, in-
crease viral uptake by neutrophils (4, 12). These latter findings
were surprising since the wild-type human or rat SP-D-NCRD
do not have viral aggregating or opsonizing activity.
For this paper, we sought to determine how NCRD mole-
cules can enhance viral uptake. We first examined the func-
tional activity of bovine CL-46-NCRD and show that, like
CL-43-NCRD, it has strong viral opsonizing activity. We then
Fig. 1. A trimeric neck and carbohydrate recognition domain (NCRD) construct of bovine serum collectin CL-46 (CL-46-NCRD) increases viral uptake by neutrophils.
Preincubation of CL-46-NCRD with influenza A virus (IAV) followed by incubation with human neutrophils caused strong increases in viral uptake (A;
CL-46-NCRDFITC-labeled IAV; P  0.05 for all doses of CL-46-NCRD compared with binding of virus alone). A shows fluorescence as % of virus only control,
and B and C show absolute fluorescence values. Significant increases in viral uptake also occurred when the neutrophils were first incubated with CL-46, followed by
washing of the cells and then addition of IAV (A; CL-46-NCRDneutrophils). Unlabeled IAV was also preincubated with CL-46-NCRD that had been labeled with
Alexa Fluor (B). Addition of these complexes to neutrophils resulted in strong increases in neutrophil fluorescence indicating binding of CL-46-NCRD to the cells,
presumably in conjunction with IAV. Carrying out these incubations in the presence of mannan or EDTA markedly decreased binding of CL-46-NCRD with neutrophils
[significantly less binding by ANOVA compared with binding of CL-46-NCRD-Alexa in control buffer (black rectangles)]. In C, Alexa Fluor-labeled CL-46-NCRD
alone was incubated with neutrophils (no virus present). The CL-46-NCRD again bounded to neutrophils in a saccharide- and calcium-dependent manner (C), but the
binding was much lower than when CL-46-NCRD had been preincubated with IAV first (B). All results are means  SE of 4 or more experiments using separate
neutrophil donors. *Significantly greater neutrophil fluorescence than control (P  0.05). GlucNAc, N-acetylglucosamine.








Amino acids 312–355 are shown. Amino acid 343 is shown in italics. and the location of ridges on either side of the lectin and calcium coordination site are
indicated. Conserved residues are shown in bold. The primary calcium coordinating residues are residues 320–322 (EPN). R343 in surfactant protein D (SP-D)
is indicated by an arrow. CRDs, carbohydrate recognition domain; hSP-D, trimers composed of human SP-D; rSP-D, trimers composed of rat SP-D.
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show that the hSP-D-NCRD/R343V and hSP-D-NCRD/R343I
mutants of the human hSP-D-NCRD, which resemble the
bovine collectins at the 343 position, acquire strong opsonizing
activity. Because hSP-D-NCRDs that promote viral uptake by
phagocytes all induce viral aggregation to a greater extent than
hSP-D-NCRD, it is likely that enhanced aggregating activity
accounts for their opsonizing activity.
MATERIALS AND METHODS
Virus preparations. IAV was grown in the chorioallantoic fluid of
10-day-old chicken eggs and purified on a discontinuous sucrose
gradient as previously described (16). The virus was dialyzed against
PBS to remove sucrose, aliquoted, and stored at 80°C until needed.
Philippines 82/H3N2 (Phil82) strain was kindly provided by Dr. E.
Margot Anders (Univ. of Melbourne, Melbourne, Australia). After
thawing, the viral stocks contained5 108 infectious focus forming
units/ml.
Collectin preparations. hSP-D-NCRD preparations, including the
wild-type hSP-D-NCRD (called hSP-D-NCRD hereafter), wild-type
rat SP-D-NCRD (rSP-D-NCRD), hSP-D-NCRD/R343V, hSP-D-
NCRD/R343I, and hSP-D-NCRD/R343IRAK mutants, were pro-
duced in Escherichia coli as previously described (4, 5). CL-46-
NCRD was expressed in Pichia pastoris and purified as previously
described (9). Briefly, the -helical coiled-coil neck region and the
CRD of CL-46 were amplified by PCR and ligated into the pPIC9K
vector (Invitrogen). The pPIC9K derivatives were transformed into
XL-10 E. coli, purified, linearized, and transformed into P. pastoris
(GS115). Clones were double-selected by growth on histidine-defi-
cient plates and plates with increasing concentrations of Geneticin.
The endotoxin level of all SP-D preparations was 0.10.5 endotoxin
units (EU)/ml (Limulus Lysate Assay, Cambrex, Walkersville, MD).
Monoclonal antibodies. MAbs 246-04 and 246-08 were raised
against SP-D by inoculating mice with 10 g/ml human SP-D as
previously described (27). Both of these MAbs bind to the hSP-D-
NCRD of human SP-D, although neither blocks binding of SP-D to
mannan or IAV (35). Both MAbs are of the IgG2a subtype. The IgG2a
isotype control antibody was obtained from eBioscience (http://www.
ebioscience.com).
Hemagglutination inhibition assay. Hemagglutination (HA) inhi-
bition was measured by serially diluting collectins or other host
defense protein preparations in round-bottom 96-well plates (Sero-
cluster U-Vinyl plates; Costar, Cambridge, MA) using PBS contain-
ing calcium and magnesium as a diluent (18). After adding 25 l of
IAV, giving a final concentration of 40 HA U/ml or 4 HA U/well, the
IAV-protein mixture was incubated for 15 min at room temperature,
followed by addition of 50 l of a type O human erythrocyte
suspension. The minimum concentration of protein required to fully
inhibit the hemagglutinating activity of the viral suspension was
determined by noting the highest dilution of protein that still inhibited
HA. Inhibition of HA activity in a given well is demonstrated by
absence of formation of an erythrocyte pellet. If no inhibition of HA
activity was observed at the highest protein concentration used then
the value is expressed as 	 the maximal protein concentration.
Measurement of viral aggregation by collectins. Viral aggregation
was measured by assessing light transmission through stirred suspen-
sions of IAV as previously described (21). In addition, viral aggre-
gates were visualized using electron microscopy (EM) as previously
described (31).
Fluorescent focus assay of IAV infectivity. Madin-Darby canine
kidney (MDCK) cell monolayers were prepared in 96-well plates and
grown to confluency. These layers were then infected with diluted
IAV preparations for 45 min at 37°C in PBS and tested for presence
of IAV infected cells after 7 h using a MAb directed against the
influenza A viral nucleoprotein [provided by Dr. Nancy Cox, Center
for Disease Control (CDC), Atlanta, GA] as previously described
(14). IAV was preincubated for 30 min at 37°C with SP-D or control
buffer, followed by addition of these viral samples to the MDCK cells.
Where indicated, SP-Ds were first incubated with MAbs before
adding them to IAV.
Neuraminidase inhibition assay. Neuraminidase (NA) activity of
IAV was measured by an enzyme-linked microplate assay in which
Arachis hypogaea (peanut) lectin was used to detect 
-D-galactose-
GlcNAc sequences exposed after the removal of sialic acid from
Fig. 2. An NCRD construct of human surfactant protein D (SP-D) with an R343V substitution (hSP-D-NCRD/R343V) increases viral uptake and IAV-induced H2O2 production
by neutrophils. A shows the effect of preincubating FITC-labeled IAV with hSP-D-NCRD/R343V, hSP-D-NCRD/R343V lacking the fusion tag, or wild-type hSP-D-NCRD on
viral uptake by neutrophils. hSP-D-NCRD did not cause any increase in viral uptake, but hSP-D-NCRD/R343V with or without the fusion tag did. At 8 g/ml
hSP-D-NCRD/R343V, the preparation lacking the fusion tag caused a significantly greater increase in uptake than hSP-D-NCRD/R343V with the fusion tag (P 0.05). B shows
neutrophil H2O2 generation as measured by decreases in scopoletin fluorescence. IAV-induced neutrophil H2O2 generation was significantly increased by preincubation of the
virus with 16 g/ml hSP-D-NCRD/R343V (P  0.05), whereas it was not after preincubation of wild-type hSP-D-NCRD. All results shown are means  SE of 3 or more
experiments. *Significantly greater neutrophil fluorescence than control virus alone (A; P 0.05) or significantly greater H2O2 generation than was induced by IAV alone or
IAVhSP-D-NCRD (assessed by ANOVA).
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fetuin (30). Wells of microtiter plate were coated with 50 l of fetuin
(20 l/ml in PBS; F2379; Sigma) overnight at 4°C and washed with
PBS. Dilutions of IAV strains with different concentrations of SP-D
were preincubated for 30 min at 37°C, and 50 l of the mixture was
added to fetuin-coated wells and incubated at 37°C for 2 h. After the
wells were washed, 50 l of peroxidase-labeled peanut lectin [20
l/ml in BSA (0.5%); L6135; Sigma] was added to each well for 30
min at room temperature followed by washing and incubation with 50
l of TMP-peroxidase (Bio-Rad, Hercules, CA) for 20 min. Finally,
50 l of 1 N H2SO4 was added to the wells, and the absorbance was
measured by ELISA plate reader at 450 nm.
Human neutrophil and monocyte preparation. Neutrophils from
healthy volunteers were isolated to 	95% purity by using dextran
precipitation, followed by Ficoll-Paque gradient separation for the
separation of mononuclear cells (layering above the Ficoll-Paque) and
neutrophils (below the Ficoll-Paque). The neutrophils were purified
further by hypotonic lysis to eliminate any contaminating erythro-
cytes, as previously described (16). Cell viability was determined to
be 	98% by trypan blue staining. The isolated neutrophils were
resuspended at the appropriate concentrations in control buffer (PBS)
and used within 2 h. Neutrophil collection was done with informed
consent as approved by the Institutional Review Board of Boston
University School of Medicine. Peripheral blood mononuclear cells
(PBMCs) were taken from the layer above Ficoll-Paque and washed
several times in PBS. For fluorescent microscopy, the mononuclear
cells were maintained in suspension and hence contained lymphocytes
and monocytes. For fluorescent microscopic assays, the mononuclear
cell preparations were allowed to adhere to plastic followed by
washing off of unattached cells. The adherent cells were predomi-
nantly monocytes. RAW cells were obtained from the American Type
Culture Collection (Manassas, VA).
Measurement of IAV uptake by neutrophils and monocytes. FITC-
labeled IAV (Phil82 strain) was prepared, and uptake of virus by
neutrophils, monocytes, or RAW cells was measured by flow cytom-
etry as previously described (15, 21). In brief, IAV was incubated with
neutrophils for 30 min at 37°C in presence of control buffer. Trypan
blue (0.2 mg/ml) was added to these samples to quench extracellular
fluorescence. Following washing, the neutrophils were fixed with
paraformaldehyde, and neutrophil-associated fluorescence was mea-
sured using flow cytometry. The mean neutrophil or monocyte fluo-
rescence (	1,000 cells counted per sample) was measured. Monocyte
uptake was also assessed by fluorescent microscopy using plastic
adherent PBMCs.
Measurement of neutrophil H2O2 production. H2O2 production
was measured by assessing reduction in scopoletin fluorescence
as previously described (17). Measurements were made using a
POLARstar OPTIMA fluorescent plate reader (BMG Labtech,
Durham, NC).
Statistics. Statistical comparisons were made using Student’s
paired two-tailed t-test or ANOVA with post hoc test (Tukey).
ANOVA was used for multiple comparisons to a single control.
RESULTS
The CL-46-NCRD strongly increases neutrophil uptake of
IAV despite lacking NH2-terminal domains. Like full-length
CL-43, the CL-43-NCRD, or the RAK insertion mutant of
hSP-D-NCRD, CL-46-NCRD increased FITC-labeled IAV up-
take by neutrophils (Fig. 1). This effect was most pronounced
when the CL-46-NCRD was preincubated with IAV (Fig. 1A,
top curve), but significant increase in uptake of the virus also
Fig. 3. hSP-D-NCRD/R343V increases IAV
uptake by human peripheral blood mononu-
clear cells (PBMCs) and by RAW 264.7 cells.
Experiments shown in A and B were performed
as in Fig. 2A, except that human PBMCs and
RAW cells were used for flow cytometry. hSP-
D-NCRD/R343V significantly increased viral
uptake by PBMCs (P  0.01 at 8 g/ml) and
RAW 264.7 cells (P  0.01 at 16 g/ml; n 
4 for each using separate blood donors for the
PBMCs). C shows adherent human PBMCs
treated with Alexa Fluor-labeled IAV alone
(control IAV) or a similar amount of virus
pretreated with 8 g/ml either hSP-D-NCRD or
hSP-D-NCRD/R343V. These photos are from
1 representative experiment of 3 that were per-
formed. *Significantly greater cellular fluores-
cence than control (P  0.05).
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occurred when neutrophils were first incubated with CL-46-
NCRD followed by addition of FITC-labeled IAV (Fig. 1A,
bottom curve). We also labeled CL-46-NCRD with Alexa
Fluor and incubated this with unlabeled IAV (Fig. 1B). This
procedure also led to a marked increase in neutrophil fluores-
cence, which was largely inhibited when the assay was carried
out in the presence of mannose or EDTA. Finally, we tested the
effect of adding CL-46-NCRD-Alexa alone to neutrophils (no
virus included) and showed a small but statistically significant
binding to the neutrophils that was inhibited by EDTA or
GlcNAc. Overall, these results suggest that CL-46-NCRD
forms a complex with IAV leading to increased uptake of the
virus and CL-46-NCRD. However, free CL-46-NCRD also
bound directly to the neutrophils through its lectin activity, and
this was able to increase binding of subsequently added IAV.
Note again that wild-type human and rat SP-D-NCRDs do not
increase neutrophil uptake of IAV in this manner (Ref. 32 and
see below). These results led us to further evaluate the contri-
butions of nonconserved residues near the carbohydrate bind-
ing site of serum collectins like CL-43 and CL-46.
Substitution of valine or isoleucine at position 343 in the
human SP-D NCRD confers viral opsonizing activity. As
shown in Table 1, a common feature of the serum collectins is
presence of a hydrophobic residue instead of the arginine found
at amino acid 343 in SP-D. The R343V substitution in hSP-
D-NCRD conferred the capacity to increase viral uptake by
neutrophils (Fig. 2A). To rule out a possible contribution of the
fusion tag to the opsonizing activity of hSP-D-NCRD/R343V,
the protein was also expressed without the tag. The “tagless”
hSP-D-NCRD/R343V also caused strong increases in neutro-
phil uptake of IAV (Fig. 2A). hSP-D-NCRD/R343V also in-
creased neutrophil H2O2 responses to IAV, whereas wild-type
hSP-D-NCRD did not (Fig. 2B). hSP-D-NCRD/R343V also
increased viral uptake by human PBMCs (Fig. 3A) or RAW
264.7 cells (Fig. 3B) as assessed by flow cytometry using
cells in suspension. A similar increase in viral uptake by
adherent PBMCs was found using fluorescence microscopy
(Fig. 3C).
We compared activity of various other wild-type and
mutant hSP-D-NCRDs with that of hSP-D-NCRD/R343V in
terms of ability to increase neutrophil uptake of IAV (Fig. 4).
hSP-D-NCRD/R343I and the combined hSP-D-NCRD/
R343IRAK mutants were prepared. The former construct
contains the isoleucine found at residue 343 in CL-43,
whereas the latter contains both isoleucine and the RAK
insertion present in CL-43. Both mutants increased neutro-
phil uptake of IAV but not to the same extent as hSP-D-
NCRD/R343V (Fig. 4). We (3) have reported that the
hSP-D-NCRD/R343V mutant has strong viral neutralizing
activity. Hence, it is likely that a major part of the enhanced
neutralizing and opsonizing activity seen with CL-46 and
CL-43 relates to the presence of the hydrophobic residue at
the 343 position. Of interest, the hSP-D-NCRD/R343V
mutant had greater opsonizing activity than hSP-D-NCRD/
R343I or the combined mutant, hSP-D-NCRD/
R343IRAK. hSP-D-NCRD/R343IRAK did not have
greater activity than the hSP-D-NCRD/R343I single mutant
but did have a very similar level of activity to CL-43-
NCRD.
hSP-D-NCRD/R343V binds to neutrophils and increases
viral uptake. As with the CL-46-NCRD, an Alexa Fluor-
labeled preparation of hSP-D-NCRD/R343V bounded to
neutrophils in a calcium-dependent manner (Fig. 5A). Bind-
ing of hSP-D-NCRD/R343V-Alexa was increased 10-fold
when it was preincubated with unlabeled IAV (Fig. 5B).
This indicates that hSP-D-NCRD/R343V forms a complex
with IAV that then binds to neutrophils. Preincubation of
neutrophils with unlabeled hSP-D-NCRD/R343V also re-
sulted increased binding of FITC-labeled IAV that was
added subsequently, and this increase significantly exceeded
that of wild-type hSP-D-NCRD (Fig. 5C); however, if the
neutrophils were washed free of unbound hSP-D-NCRD/
R343V or hSP-D-NCRD before addition of IAV, no in-
crease in viral uptake occurred. The latter result differs from
that obtained with the CL-46-NCRD where some increased
uptake was observed. These results suggest that direct
binding of hSP-D-NCRD/R343V to neutrophils does not
play a significant role in it opsonizing activity.
hSP-D-NCRD/R343V and CL-46-NCRDs induce viral ag-
gregation. Using light transmission assays, we found that
hSP-D-NCRD/R343V caused a subtle viral aggregation re-
sponse (Fig. 6A). Of interest, the tagless hSP-D-NCRD/
R343V caused greater aggregation that hSP-D-NCRD/
R343V containing the fusion tag, and both caused signifi-
cantly greater viral aggregation than hSP-D-NCRD (which
Fig. 4. Comparison of ability of various wild-type or mutant hSP-D-NCRDs to
increase neutrophil uptake of IAV. FITC-labeled IAV was preincubated with
16 g/ml wild-type human or rat (r) SP-D-NCRDs, CL-43-NCRD, or various
other mutant versions of hSP-D-NCRD followed by measurement of viral
uptake by human neutrophils. Results are expressed as % of control uptake
(control  untreated virus). CL-43-NCRD and the mutants, hSP-D-NCRD/
R343I, hSP-D-NCRD/R343IRAK (where RAK indicates arginine, alanine,
and lysine insertion; labeled R343VRAK in figure), and hSP-D-NCRD/
R343V, all caused increased uptake (* or ** indicate P  0.05 compared with
virus alone). The increase in uptake caused by hSP-D-NCRD/R343V was
significantly greater than that caused by CL-43-NCRD, hSP-D-NCRD/R343I,
or hSP-D-NCRD/R343IRAK as assessed by ANOVA (indicated by **).
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did not result in significant aggregation compared with
control virus alone). To confirm that the effect was not
secondary to aggregation of the protein during storage, an
aliquot of purified hSP-D-NCRD/R343V fusion protein was
reexamined by gel filtration under the conditions of original
isolation; the protein eluted exclusively as a trimer (Ref. 4
and data not shown). Since the gel filtration is carried out in
500 mM NaCl without added calcium, we cannot completely
exclude that some protein aggregation occurs after addition
of calcium during the incubation with the virus; however,
we have also prepared the protein at much higher concen-
trations in physiological buffer (including calcium) for crys-
tallography and encountered no protein aggregation under
those conditions (3). A subtle but statistically significant
aggregation response by CL-46-NCRD was also observed
using the light transmission assay (Fig. 6B). These aggre-
gation responses were less than we have reported with
full-length SP-D dodecamers; hence, we decided to evaluate
viral aggregation using EM. As shown in Fig. 6C, viral
aggregation caused by hSP-D-NCRD/R343V and CL-46-
NCRD was also readily apparent by transmission EM and
greatly exceeded the response induces by hSP-D-NCRD.
CL-43-NCRD also caused a subtle increase in viral aggre-
gation compared with hSP-D-NCRD. Note that CL-43-
NCRD causes greater uptake of IAV, and greater viral
aggregation, at 32 g/ml (data not shown), but the results
obtained with 16 g/ml are shown here for comparison with
hSP-D-NCRD/R343V and CL-46-NCRD. It should be noted
that the CL-46-NCRD used in these studies was prepared by
a different method (i.e., in P. pastoris) from the other
NCRDs and thus direct comparisons of activity between
CL-46-NCRD and the others NCRDs must be interpreted
with caution.
Cross-linking of hSP-D-NCRD/R343V increases its viral
aggregating and opsonizing activity and confers NA inhibition
activity. We have shown that certain MAbs directed against the
hSP-D-NCRD do not block activity of SP-D but strongly
increase the ability of the wild-type hSP-D-NCRD to bind to
and neutralize the virus (32). These MAbs, 246-04 and 246-08,
likely bind to the lateral or back surface of the CRD head and
cross-link the trimers resulting in greater binding and antiviral
activity. As shown in Fig. 7A, MAb 246-08 potentiated the
ability of hSP-D-NCRD/R343V to cause viral aggregation. We
(30) have previously shown that the ability of SP-D to inhibit
viral NA activity is strongly dependent on multimerization.
Despite strong activity on various other assays, hSP-D-NCRD/
R343V alone did not inhibit viral NA activity; however, it did
so when coincubated with MAb 246-04 or 246-08 (Fig. 7B).
MAb 246-08 also enabled hSP-D-NCRD/R343V to increase
neutrophil uptake of IAV at lower concentrations than when
hSP-D-NCRD/R343V was used alone (Fig. 8A). MAb 246-08
also potentiated the ability of hSP-D-NCRD/R343V to increase
IAV-induced H2O2 production (Fig. 8B). Of interest, the MAb
actually antagonized the ability of higher concentrations (20
g/ml) of hSP-D-NCRD/R343V to increase neutrophil uptake
of IAV. The 246-04 and 246-08 MAbs are of the IgG2a
subtype. An IgG2a isotype control MAb alone had no effect on
viral uptake and did not significantly alter the effects of 4
g/ml hSP-D-NCRD or hSP-D-NCRD/R343V on viral uptake
(n  3 experiments using separate neutrophil donors; data not
Fig. 5. Role of binding of hSP-D-NCRD/R343V to neutrophils in its ability to promote viral uptake. A shows that Alexa Fluor-labeled hSP-D-NCRD/
R343V bounded to neutrophils in a manner that was significantly reduced in presence of EDTA (P  0.01 comparing EDTA vs. control buffer at 32 g/ml;
n  6). B shows effect of preincubating hSP-D-NCRD/R343V-Alexa with unlabeled IAV on binding of hSP-D-NCRD/R343V. Note 10-fold increase
in neutrophil-associated fluorescence compared with hSP-D-NCRD/R343V-Alexa in absence of IAV. C shows the effect of preincubation of neutrophils
with hSP-D-NCRD/R343V or hSP-D-NCRD (30 min at 37°C) on uptake of FITC-IAV added subsequently. Both hSP-D-NCRD and hSP-D-NCRD/R343V
caused significant increases in neutrophil uptake of IAV using this method (P  0.05 for all doses; n  8); however, the effect of hSP-D-NCRD/R343V
was significantly greater at the 16 g/ml concentration by ANOVA. In contrast, if unbound hSP-D-NCRD/R343V or hSP-D-NCRD were washed off of
neutrophils before addition of IAV, no increase in viral uptake was found (n  4). *Significantly greater neutrophil fluorescence than control (P  0.05).
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shown). Note also that MAb 246-08 alone did not alter IAV
uptake by neutrophils or IAV-induced neutrophil H2O2 re-
sponses (Fig. 8B). Hence, it is unlikely that the effects shown
in Fig. 8 result from nonspecific binding of MAb 246-08 to
neutrophil Fc receptors.
DISCUSSION
We (4, 19) have previously shown that trimers of CL-43
(either full-length or in NCRD form) and hSP-D-NCRD with
an insertion of the RAK sequence are able to increase uptake
of IAV by neutrophils. By contrast, wild-type human or rat
SP-D-NCRDs or the full-length RrSP-Dser15,20 trimers did
not have this effect. We now show that CL-46-NCRD also
promotes viral uptake by neutrophils. Because the NCRDs do
not contain NH2-terminal or collagen domains, these domains
are not involved in opsonizing activity.
The key residues that affect binding of SP-D to glycosylated
ligands are those present on the ridges flanking the lectin site
(e.g., D325 and R343). The RAK insertion lies adjacent to
D325 and probably alters or extends the binding surface in that
area, allowing a small increase in neutralizing activity and
resulting in increases in viral uptake at high concentrations of
hSP-D-NCRD; however, the opsonizing activity of CL-46 was
much greater than that of RAK, and CL-46 has a distinct
insertion in this location (NN). Another common feature of
serum collectins that distinguishes them from SP-D is the
presence of a hydrophobic residue at 343. We (3) have reported
that the hSP-D-NCRD/R343V mutant of hSP-D-NCRD has
Fig. 6. hSP-D-NCRD/R343V and CL-46-NCRD
cause aggregation of IAV. A shows aggregation of
IAV as measured by light transmission through
stirred viral suspensions. hSP-D-NCRD/R343V
and hSP-D-NCRD/R343V lacking the fusion tag
both caused significant viral aggregation (P 0.01
at points indicated by *; n 4), whereas wild-type
hSP-D-NCRD did not. The hSP-D-NCRD/R343V
without fusion tag caused significantly greater ag-
gregation than hSP-D-NCRD/R343V with the tag
(labeled hSP-D-NCRD/R343V) as assessed by
ANOVA. B shows aggregation caused by CL-46-
NCRD (P  0.05 compared with control virus
where indicated by *; n 3). C shows viral control
and aggregation caused by hSP-D-NCRD, CL-43-
NCRD, CL-46-NCRD, and hSP-D-NCRD/
R343V under electron microscopy (all 16 g/ml).
Results are representative of 3 experiments.
Fig. 7. Cross-linking of hSP-D-NCRD/R343V by
MAbs increases viral aggregating activity and results
in neuraminidase (NA) inhibition. The effects of
hSP-D-NCRD/R343V and hSP-D-NCRD/R343V
combined with the MAb 246-08 on viral aggregation
are shown in A. hSP-D-NCRD/R343V caused viral
aggregation compared with virus alone (P  0.05,
indicated by *). Aggregation was significantly greater
(P  0.05 where indicated by **; n  4) with the
addition of the MAb. NA inhibition was measured by
reduction in binding of peanut lectin to fetuin (B).
hSP-D-NCRD/R343V alone did not cause any inhi-
bition of NA activity; however, significant inhibition
did occur when hSP-D-NCRD/R343V was com-
bined with the MAbs 246-08 or 246-04 (P  0.05
compared with control as indicated by *; n 4). The
concentration of MAbs used in these assays was 5
g/ml.
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markedly increased neutralizing activity and now demonstrate
that hSP-D-NCRD/R343V also has strong opsonizing activity.
hSP-D-NCRD/R343I had increased neutralizing activity com-
pared with hSP-D-NCRD but not as great as hSP-D-NCRD/
R343V, and its opsonizing activity was also less. We have
recently found that the CL-46-NCRD has increased HA inhi-
bition and neutralizing activity compared with hSP-D-NCRD
(K. L. Hartshorn, G. Sorensen, U. Holmskov, and E. C.
Crouch, unpublished data). Although CL-43 and CL-46 have
insertions near 325, it is not clear whether these insertions
contribute to the enhanced opsonizing activity, since the com-
bined RAKhSP-D-NCRD/R343I mutant had less opsonizing
activity than hSP-D-NCRD/R343I alone.
We demonstrate that the opsonizing activity of hSP-D-
NCRD/R343V is not confined to neutrophils but is also present
for PBMCs and RAW cells. It is particularly notable that
hSP-D-NCRD/R343V and other mutant hSP-D-NCRDs are
able to act as opsonins because these preparations fully lack
NH2-terminal and collagen domains and do not form multim-
ers. A variety of studies support the concept that NH2-terminal
and collagen domains are important for binding to macrophage
surface receptors and that these receptors play important roles
in promotion of phagocytosis and cell activation in response to
complexes of collectins and microbial or apoptotic cell ligands
(6, 25). Our results convincingly show, however, that trimeric
collectin hSP-D-NCRDs can also act as opsonins to enhance
neutrophil or monocyte/macrophage uptake of IAV. We have
recently shown that small dodecamers of SP-D lacking the
collagen domain but retaining the NH2 terminus and hSP-D-
NCRD trimers cross-linked with MAbs also promote neutrophil
uptake of IAV (32, 34). Hence, using several methods, we have
shown that the collagen domain per se in not required for antiviral
or opsonizing activity. The current results further demonstrate that
these activities can be reproduced even in the absence of higher
levels of multimerization or cross-linking of trimers.
Both hSP-D-NCRD/R343V and CL-46-NCRD showed de-
tectable calcium-dependent binding to neutrophils; however,
this does not appear to be a major factor in their ability to
increase viral uptake. Preincubation of neutrophils with CL-
46-NCRD or hSP-D-NCRD/R343V followed by later addition
of IAV increased viral uptake. In the case of hSP-D-NCRD/
R343V, this effect was abolished by thoroughly washing off
unbound hSP-D-NCRD/R343V, and washing off unbound CL-
46-NCRD greatly decreased its opsonizing activity. The more
likely explanation for their opsonizing activity is their shared
ability to cause viral aggregation. This mechanism is similar to
that we (31) recently proposed for some defensins. As for
defensins, the aggregating activity of CL-46-NCRD or hSP-D-
NCRD/R343V was much more evident by EM than with light
transmission assays (31). The mechanism through which a
trimer can induce aggregation is still unclear since we did not
find any evidence of self-aggregation in the hSP-D-NCRD/
R343V preparation. It is likely that an hSP-D-NCRD trimer
can cross-link IAV particles when a sufficient amount of the
Fig. 8. Cross-linking of hSP-D-NCRD/R343V with MAb modifies its ability to increase neutrophil uptake of IAV and increases its ability to potentiate
IAV-induced neutrophil H2O2 generation. Neutrophil uptake of IAV (A) and IAV-induced neutrophil H2O2 generation (B) were measured as in Fig. 3.
hSP-D-NCRD/R343V alone increased IAV uptake compared with IAV alone (P  0.05 where indicated by *). At lower concentrations (2 and 4 g/ml) of
hSP-D-NCRD/R343V, addition of MAb 246-08 (labeled MAb in figure) significantly increased the ability of hSP-D-NCRD/R343V to increase neutrophil uptake
of IAV (significant difference by ANOVA indicated by **; n  5 using separate neutrophil donors). The MAb alone (without NCRDs) did not significantly alter
neutrophil uptake of IAV (data not shown). In contrast, addition of the MAb significantly reduced neutrophil uptake compared with 16 g/ml hSP-D-NCRD/
R343V alone (# indicates where hSP-D-NCRD/R343V caused significantly greater increase in neutrophil fluorescence than the combination of hSP-D-NCRD/
R343V and MAb 246-08 as determined by ANOVA). The MAb alone had no effect on viral uptake (data not shown). hSP-D-NCRD/R343V alone at 4 g/ml
(lower than concentration used in Fig. 3) did not increase IAV-induced neutrophil H2O2 generation, nor did MAb 246-08 alone (B); however, the combination
of hSP-D-NCRD/R343V and the MAb caused marked enhancement of neutrophil H2O2 generation (n  4; P  0.01 compared with control or hSP-D-NCRD/
R343V or MAb alone, indicated by *).
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hSP-D-NCRD is present in relation to the viral concentration.
This implies that individual lectin sites on a trimer can bind to
separate viral particles if the affinity for viral saccharides is
high enough. Alternatively, hSP-D-NCRD/R343V or CL-46-
NCRD could self-aggregate after binding to the viral ligand,
leading to aggregation.
Of additional interest, the antiviral activities of hSP-D-
NCRD/R343V and other mutant hSP-D-NCRDs were further
increased by cross-linking of the hSP-D-NCRDs with MAbs.
We have previously shown that these MAbs bind to the
hSP-D-NCRD but not to the neck or the area adjacent to the
lectin site (23, 32). These antibodies are able to cross-link
hSP-D-NCRD such that it can mediate neutralizing and other
antiviral activities (32). We now show that these MAbs also
increase the ability of hSP-D-NCRD/R343V to cause viral
aggregation and potentiate neutrophil uptake of IAV and neu-
trophil respiratory burst responses. At suboptimal concentra-
tions of hSP-D-NCRD/R343V for promotion of viral uptake or
respiratory burst responses of neutrophils, the MAbs potenti-
ated opsonizing activities. Of interest, however, MAb inter-
fered with enhancement of uptake by optimal doses of hSP-
D-NCRD/R343V. It is possible that the combination of higher
concentrations of hSP-D-NCRD/R343V and the MAb results
in aggregates that are too large to be ingested by neutrophils.
However, further study will be needed to clarify this issue.
Although hSP-D-NCRD/R343V did not inhibit viral NA
activity on its own, it did so when the MAbs were added. Our
current hypothesis is that NA inhibition by collectins relies on
binding to the HA and steric hindrance of the NA such that it
cannot reach surface-bound sialic acid ligands (30). It is
possible that the hSP-D-NCRD/R343V trimer is not as effec-
tive as full-length collectins at inhibiting NA activity due to its
smaller size and that cross-linking by the MAbs allows it to
mediate greater steric hindrance of NA activity.
Summary. NCRD trimers of collectins can mediate increased
uptake of virus by neutrophils and monocytes. This activity can
be modulated by introduction of specific mutations around the
lectin site of hSP-D-NCRD that increase the apparent affinity
of the hSP-D-NCRD for IAV and neutralizing activity. It is
likely that enhanced uptake relates to viral aggregating activity
of the hSP-D-NCRD in a manner similar to that described for
the full-length molecules. We infer that binding activity of
individual CRDs is sufficiently great to allow bridging inter-
actions by trimers. Thus far, all of the hSP-D-NCRDs that can
serve as opsonins for IAV also have increased viral binding
and antiviral activity. Given the phenotype of hSP-D-NCRD/
R343V and related mutants, this is likely dependent on the
presence of a hydrophobic residue at position 343, with further
contributions of other residues on the CRD. Aggregating and
opsonizing activity of mutant hSP-D-NCRDs can be further
enhanced by cross-linking with MAbs that bind to hSP-D-
NCRD without inhibiting its lectin activity. Hence, these activities
of hSP-D-NCRD can be increased both by modification of key
CRD residues to improve viral binding and by cross-linking of
hSP-D-NCRD trimers. The latter effect can be accomplished with
MAbs or through modification of NH2-terminal and collagen
domains to optimize multimeric assembly.
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